tiprankstipranks
Trending News
More News >
International Flavors & Fragrances (IFF)
NYSE:IFF

International Flavors & Fragrances (IFF) AI Stock Analysis

Compare
687 Followers

Top Page

IF

International Flavors & Fragrances

(NYSE:IFF)

56Neutral
IFF's stock score reflects a mixed performance with strengths in operational improvements and strategic growth highlighted in the earnings call. However, significant profitability challenges and high leverage weigh on the overall score. The technical indicators suggest short-term stability, but valuation metrics remain a concern given the negative P/E ratio.
Positive Factors
Financial Performance
IFF has delivered six sequential quarterly beats compared to consensus, indicating strong performance and consistency.
Growth Prospects
There is scope for IFF to grow at three times the US Consumer Staples LFL levels over 2025/26, supported by a diversified customer footprint, innovation, and regulatory reformulation tailwinds.
Valuation
IFF is trading at a significant discount of more than 25% to 2025 PER, presenting an opportunity to re-enter the shares.
Negative Factors
Earnings Projections
The adjusted EPS projections for FY25/26/27 have been revised lower, leading to a decrease in the price target for IFF.
Market Sentiment
IFF's share price tumbled -8% on 1Q25 results following comments on the conference call about potential pre-buying and risk of trading softening due to the mixed market/macro backdrop.
Product Vulnerability
IFF estimates that 80% of its products are in core products and 20% are discretionary and more vulnerable to a cyclical shock.

International Flavors & Fragrances (IFF) vs. S&P 500 (SPY)

International Flavors & Fragrances Business Overview & Revenue Model

Company DescriptionInternational Flavors & Fragrances (IFF) is a leading global creator of flavors and fragrances used in a wide variety of consumer products. The company operates across several sectors including food and beverage, home and personal care, and health and wellness. IFF's core products and services include the development and manufacturing of natural and synthetic flavor compounds, fragrance ingredients, cosmetic actives, and other specialty ingredients that are integral to the consumer goods industry.
How the Company Makes MoneyIFF makes money through its diverse portfolio of flavors, fragrances, and specialty ingredients, which are sold to manufacturers of consumer products worldwide. Its revenue model is based on the sale of these compounds to industries such as food and beverage, where it provides flavor solutions, and the personal care and household products sectors, where it offers fragrance and cosmetic solutions. Key revenue streams include long-term contracts with major consumer goods companies, proprietary product formulations, and innovation in sustainable and natural ingredients. Additionally, strategic partnerships and acquisitions enhance its market presence and technological capabilities, contributing significantly to its earnings.

International Flavors & Fragrances Financial Statement Overview

Summary
IFF shows signs of recovery with improved profitability and debt management. However, revenue stagnation and cash flow challenges present potential risks. The company is stabilizing post losses, but growth remains a concern.
Income Statement
55
Neutral
The income statement reveals mixed performance. Gross profit margin has improved from 32.06% in 2023 to 35.91% in 2024, indicating better cost management. However, with a net profit margin of 2.12% in 2024, the company still struggles with profitability, though this is an improvement from a significant net loss in 2023. Revenue has slightly increased from $11.48B in 2023 to $11.48B in 2024, showing stagnation. The EBIT margin improved to 6.67% in 2024 from 5.33% in 2023, indicating operational improvements.
Balance Sheet
60
Neutral
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.69 in 2024, reduced from 0.74 in 2023, indicating prudent debt management. Return on equity improved to 1.75% in 2024 from a negative in 2023, showing recovery potential. However, the equity ratio decreased to 48.39% in 2024 from 47.17% in 2023, suggesting a slight weakening in equity financing relative to assets.
Cash Flow
50
Neutral
Cash flow analysis shows a decrease in free cash flow from $936M in 2023 to $607M in 2024, indicating challenges in cash generation. The operating cash flow to net income ratio improved, reflecting efficient cash generation relative to profit, but free cash flow to net income remains pressured by capital expenditures.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
11.48B11.48B12.44B11.66B5.08B
Gross Profit
4.12B3.68B4.15B3.73B2.09B
EBIT
766.00M612.00M1.09B585.00M566.48M
EBITDA
1.60B-996.00M-110.00M1.80B897.67M
Net Income Common Stockholders
243.00M-2.56B-1.84B268.00M365.00M
Balance SheetCash, Cash Equivalents and Short-Term Investments
469.00M703.00M493.00M715.00M656.84M
Total Assets
28.67B30.98B35.39B39.68B13.56B
Total Debt
9.59B10.80B10.97B11.40B4.41B
Net Debt
9.12B10.10B10.48B10.69B3.76B
Total Liabilities
14.76B16.34B17.60B18.45B7.14B
Stockholders Equity
13.88B14.61B17.73B21.12B6.32B
Cash FlowFree Cash Flow
607.00M936.00M-161.00M1.04B522.30M
Operating Cash Flow
1.07B1.44B345.00M1.44B714.10M
Investing Cash Flow
326.00M574.00M745.00M-18.00M-187.46M
Financing Cash Flow
-1.61B-1.85B-1.18B-1.30B-511.57M

International Flavors & Fragrances Technical Analysis

Technical Analysis Sentiment
Positive
Last Price77.88
Price Trends
50DMA
76.24
Positive
100DMA
79.79
Negative
200DMA
88.03
Negative
Market Momentum
MACD
0.27
Negative
RSI
54.89
Neutral
STOCH
73.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IFF, the sentiment is Positive. The current price of 77.88 is above the 20-day moving average (MA) of 76.70, above the 50-day MA of 76.24, and below the 200-day MA of 88.03, indicating a neutral trend. The MACD of 0.27 indicates Negative momentum. The RSI at 54.89 is Neutral, neither overbought nor oversold. The STOCH value of 73.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IFF.

International Flavors & Fragrances Risk Analysis

International Flavors & Fragrances disclosed 30 risk factors in its most recent earnings report. International Flavors & Fragrances reported the most risks in the “Legal & Regulatory” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

International Flavors & Fragrances Peers Comparison

Overall Rating
UnderperformOutperform
Sector (50)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
SXSXT
74
Outperform
$4.01B31.2111.87%1.74%6.30%41.01%
RPRPM
73
Outperform
$14.89B23.2425.53%1.72%-0.61%15.06%
EMEMN
69
Neutral
$9.49B10.5216.16%3.99%2.78%1.50%
LYLYB
66
Neutral
$19.02B18.487.19%9.06%-6.53%-50.08%
PPPPG
63
Neutral
$25.94B19.3218.47%2.35%-7.67%-0.58%
IFIFF
56
Neutral
$19.78B83.39-6.08%2.07%0.68%66.69%
50
Neutral
$1.98B-1.08-21.29%3.61%1.96%-30.59%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IFF
International Flavors & Fragrances
77.88
-18.30
-19.03%
EMN
Eastman Chemical
82.35
-14.28
-14.78%
LYB
LyondellBasell
58.52
-35.70
-37.89%
PPG
PPG Industries
113.79
-16.88
-12.92%
RPM
RPM International
114.53
3.67
3.31%
SXT
Sensient Technologies
94.73
20.30
27.27%

International Flavors & Fragrances Earnings Call Summary

Earnings Call Date:May 06, 2025
(Q1-2025)
|
% Change Since: -1.67%|
Next Earnings Date:Aug 11, 2025
Earnings Call Sentiment Positive
IFF had a strong start to 2025 with solid growth in key segments and successful strategic divestitures. However, challenges remain in the Food Ingredients segment, and macroeconomic and tariff-related complexities could impact future performance.
Q1-2025 Updates
Positive Updates
Solid Start to Fiscal Year 2025
IFF reported a 3% comparable currency neutral sales growth to $2.8 billion for Q1 2025, driven by strong volume growth across most business segments including Taste, Pharma Solutions, Scent, and Health & Biosciences.
EBITDA and Margin Expansion
Adjusted operating EBITDA increased by 9% on a comparable currency neutral basis to $578 million, with the EBITDA margin rising over 120 basis points to 20.3%, marking the fourth consecutive quarter of margin expansion.
Successful Divestiture of Pharma Solutions
IFF completed the divestiture of its Pharma Solutions segment to Roquette two months ahead of schedule, achieving a net debt to EBITDA ratio below 3 times.
Taste Segment Performance
The Taste segment achieved a 7% year-over-year increase on a comparable currency neutral basis, with strong profitability driven by volume growth, favorable net pricing, and productivity gains.
Negative Updates
Volume Decline in Food Ingredients
Volume declined in the Food Ingredients segment, primarily due to weaker performance in protein solutions and planned lower pectin sales as the company shifted focus to higher-margin businesses.
Macroeconomic and Tariff Challenges
IFF faces challenges from global tariffs, particularly those impacting China, which could introduce complexity to supply chains and cost structures, with exposure of over $100 million for 2025.
Company Guidance
During the first quarter of 2025, IFF reported solid growth with a 3% increase in comparable currency-neutral sales, reaching approximately $2.8 billion. The company achieved a 9% increase in comparable currency-neutral adjusted operating EBITDA, totaling $578 million, and an expansion of the adjusted operating EBITDA margin by 120 basis points to 20.3%. This performance was driven by broad-based growth across key segments, including Taste, Pharma Solutions, Scent, and Health & Biosciences, while Food Ingredients experienced a decline due to strategic shifts and capacity limitations. Despite macroeconomic uncertainties, IFF maintains its guidance for the full year, expecting sales between $10.6 billion and $10.9 billion, representing 1% to 4% currency-neutral growth, and adjusted operating EBITDA ranging from $2 billion to $2.15 billion, signifying 5% to 10% growth on a currency-neutral basis. The company successfully completed the divestiture of Pharma Solutions, strengthening its capital structure by achieving a net debt to credit-adjusted EBITDA ratio below 3 times.

International Flavors & Fragrances Corporate Events

Executive/Board ChangesShareholder Meetings
International Flavors & Fragrances Holds Annual Shareholder Meeting
Neutral
May 7, 2025

On May 1, 2025, International Flavors & Fragrances Inc. held its Annual Meeting of Shareholders where ten directors were elected, PricewaterhouseCoopers LLP was ratified as the independent auditor for 2025, and executive compensation was approved. These decisions reflect the company’s ongoing governance and operational strategies, potentially impacting its market positioning and stakeholder relations.

Spark’s Take on IFF Stock

According to Spark, TipRanks’ AI Analyst, IFF is a Neutral.

IFF’s overall stock score reflects its recovery trajectory, with improved profitability and debt management. However, the stock is currently experiencing bearish technical signals and appears overvalued, leading to a tempered outlook despite positive elements from recent earnings.

To see Spark’s full report on IFF stock, click here.

Business Operations and StrategyFinancial Disclosures
International Flavors & Fragrances Reorganizes Business Segments
Neutral
May 6, 2025

In 2025, International Flavors & Fragrances Inc. reorganized its internal structure, affecting how resources are allocated and financial performance is assessed. This led to the separation of its former Nourish segment into two new segments: Taste and Food Ingredients. The reorganization aims to align with the company’s updated operating model and improve investor transparency by recasting 2024 financial data to reflect these changes. The new reportable segments as of Q1 2025 are Taste, Food Ingredients, Health & Biosciences, Scent, and Pharma Solutions.

Spark’s Take on IFF Stock

According to Spark, TipRanks’ AI Analyst, IFF is a Neutral.

IFF’s overall stock score reflects its recovery trajectory, with improved profitability and debt management. However, the stock is currently experiencing bearish technical signals and appears overvalued, leading to a tempered outlook despite positive elements from recent earnings.

To see Spark’s full report on IFF stock, click here.

Executive/Board Changes
IFF Executive Vice President Jennifer Johnson Resigns
Neutral
Mar 13, 2025

On March 12, 2025, Jennifer Johnson, the Executive Vice President, General Counsel, and Corporate Secretary of IFF, announced her resignation. She will remain with the company until July 1, 2025, to facilitate a smooth transition, and her departure is considered a qualifying event under IFF’s executive severance policy.

Executive/Board Changes
International Flavors & Fragrances Announces Leadership Change
Neutral
Feb 20, 2025

On February 20, 2025, International Flavors & Fragrances Inc. announced the upcoming departure of Simon Herriott, President of Health & Biosciences, effective March 31, 2025. Leticia Goncalves Lourenço will succeed him as President of the Health & Biosciences division starting March 1, 2025, marking a significant leadership change within the company.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.